Formula Grant 15PBJA25GG02347RSAT
- The Bureau of Justice Assistance awarded a $580,444 Residential Substance Abuse Treatment (RSAT) for State Prisoners Formula Grant to the Washington State Health Care Authority. The 4-year grant, effective October 1, 2023, will fund evidence-based substance use disorder (SUD) treatment and medication-assisted treatment (MAT) services for incarcerated individuals at the Jefferson County Jail, Island County Jail, and the Washington State Corrections Center for Women. The program aims to address...
- The Washington State Health Care Authority will receive $478,167 from the Department of Justice Office of Justice Programs Bureau of Justice Assistance under the Residential Substance Abuse Treatment for State Prisoners (RSAT) program (CFDA 16.593) from October 1, 2021 to September 30, 2024. The RSAT program aims to increase access to evidence-based substance use disorder treatment and reduce overdose deaths. Funding will support the Authority's jail-based RSAT program in Tumwater, Washington,...
- The Health Care Authority in Washington state was awarded $564,566 under the Residential Substance Abuse Treatment for State Prisoners program administered by the Department of Justice's Bureau of Justice Assistance. The funding will support the Authority's efforts to expand access to medication-assisted treatment for opioid use disorder among incarcerated individuals in Jefferson and Island county jails from October 1, 2022 through September 30, 2026. Approximately 60% of those incarcerated...
- This $425,352 federal Formula Grant award from the Bureau of Justice Assistance (CFDA 16.593 - Residential Substance Abuse Treatment for State Prisoners Program) supports the Washington State Health Care Authority's (HCA) efforts to provide evidence-based substance use disorder (SUD) treatment and aftercare services for incarcerated individuals at four correctional facilities in Washington state. The project aims to create therapeutic environments and deliver a range of evidence-based,...
- This federal Formula Grant award from the U.S. Department of Justice's Bureau of Justice Assistance (BJA) provides $118,765 to the DC Office of Victim Services and Justice Grants (OVSJG) to fund the Residential Substance Abuse Treatment (RSAT) for State Prisoners Program (CFDA 16.593). The program aims to address the high rates of substance use disorders and co-occurring mental health conditions among the incarcerated population in Washington, D.C. The grant will support OVSJG in operating a...
- The District of Columbia Office of Victim Services and Justice Grants (DCOVSJG) will receive $139,626 under a Formula Grant award from the Department of Justice Office of Justice Programs Bureau of Justice Assistance Residential Substance Abuse Treatment for State Prisoners program (RSAT). The grant will support the DC Department of Corrections' (DOC) jail-based substance abuse treatment program (RSAT Program) which provides clinically managed low-intensity substance use disorder and...
- The Department of Justice Office of Justice Programs Bureau of Justice Assistance awarded the Criminal Justice Coordinating Council $601,810 on October 1, 2025, under the Residential Substance Abuse Treatment for State Prisoners (RSAT) formula grant program (CFDA 16.593). CJCC, established as Georgia's state administering agency for criminal justice grant programs, will strengthen and expand substance use disorder treatment for individuals in corrections across both secure residential settings...
- The Bureau of Justice Assistance awarded the Virginia Department of Criminal Justice Services $353,824 on October 1, 2025, under the Residential Substance Abuse Treatment for State Prisoners program (CFDA 16.593) to expand and strengthen substance use disorder treatment and reentry services across Virginia's correctional system. The award funds the Virginia RSAT Program, which delivers structured residential treatment grounded in cognitive behavioral therapy to incarcerated individuals with...
- The Puerto Rico Department of Corrections and Rehabilitation received a $241,293 Formula Grant award from the U.S. Department of Justice's Bureau of Justice Assistance (BJA) under the Residential Substance Abuse Treatment (RSAT) for State Prisoners Program (CFDA 16.593). The grant aims to enhance the delivery of evidence-based substance abuse treatment services within the Commonwealth's correctional facilities. The program is designed to reduce the prevalence of substance use disorders among...
- The Department of Justice Office of Justice Programs Bureau of Justice Assistance awarded a $243,131 Formula Grant to the Executive Office of the State of Utah on October 1, 2021 through the Residential Substance Abuse Treatment for State Prisoners program (CFDA 16.593). The grant will fund substance abuse treatment services delivered through September 30, 2025. Under the award, Washington County Court Support Services will collaborate with the Washington County Sheriff's Department to provide a...
The Department of Justice Office of Justice Programs Bureau of Justice Assistance awarded $213,544 to the Washington State Health Care Authority on October 1, 2025, under the Residential Substance Abuse Treatment for State Prisoners program (CFDA 16.593) to operate the Washington State RSAT Program providing jail and prison-based residential substance use disorder treatment and aftercare support at Jefferson County Jail, Island County Jail, and the Washington State Corrections Center for Women. The program delivers evidence-based treatment services including cognitive behavioral therapy, motivational interviewing, dialectical-behavior therapy, cognitive processing therapy, seeking safety, eye movement desensitization and reprocessing, written exposure therapy, prolonged exposure therapy, group therapy, and skill-building sessions. Enhanced programming includes a weekend work program to obtain food handlers permits and educational opportunities to support high school diploma or general education development completion. All three sites maintain connections to community behavioral health agencies to secure aftercare services, including continuation of treatment and case management services post-release. The award supports treatment and skills development for incarcerated individuals with substance use disorders, addressing cognitive, behavioral, social, and vocational competencies. Place of performance is Olympia, Washington. The period of performance runs from October 1, 2025, through September 30, 2029. This is a formula grant, a classification within the broader program structure designed to improve substance use treatment during and after incarceration to reduce recidivism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $213.5k | 6/25/26 |